# Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

> **NCT01126970** · PHASE2 · COMPLETED · sponsor: **Shionogi** · enrollment: 486 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Velneperit 400 mg
- **DRUG:** Orlistat 120 mg
- **DRUG:** Orlistat Placebo
- **DRUG:** Velneperit Placebo
- **OTHER:** Reduced Calorie Diet

## Key facts

- **NCT ID:** NCT01126970
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-01
- **Final completion:** 2011-02
- **Target enrollment:** 486 (ACTUAL)
- **Last updated:** 2018-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01126970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01126970, "Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01126970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*